🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the study is the evaluation of efficacy and safety of obin...
Status
Terminated
Location
Centrum Onkologii - Instytut im. Marii Skłodowskiej- Curie Klinika Nowotworów Układu Chłonnego
Start Date
2018-05-14
Trial ID
NCT03229382
Treatments Being Tested
OUR OVERALL HYPOTHESIS is that post-transfusion survival of allogeneic and ...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2008-06
Trial ID
NCT00731588
This is a Phase III, randomized, unblinded, multicenter, prospective compar...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2011-01
Trial ID
NCT01278927
Treatments Being Tested
The purpose of this study is to evaluate the safety of epoetin alfa and its...
Status
Completed
Location
Multiple Locations
Start Date
1989-05
Trial ID
NCT00270062
Treatments Being Tested
Women undergoing myeloablative allogeneic hematopoietic cell transplant (MA...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2011-07
Trial ID
NCT01343368
Treatments Being Tested
This is a single institution phase I/II study using an ADAM17 inhibitor (IN...
Status
Completed
Location
University of Minnesota Medical Center, Fairview
Start Date
2014-05
Trial ID
NCT02141451
The purpose of this study is to evaluate the safety and effectiveness of ep...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00270114
Treatments Being Tested
The purpose of this study is to study taste disturbances on patients with m...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2017-08-28
Trial ID
NCT03276481
This phase 1/2 trial aims to determine the safety and feasibility of antiCD...
Status
Active Not Recruiting
Location
Children's Hospital of Los Angeles
Start Date
2020-01-08
Trial ID
NCT03971799
Treatments Being Tested
This phase III trial studies rituximab after stem cell transplant and to se...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-11-27
Trial ID
NCT03267433